Clinical Trial Update: Efficacy and Safety of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on the efficacy and safety of Maridebart Cafraglutide for obesity in adults in Japan; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Maridebart Cafraglutide

Snippet

Sponsor: Amgen | Conditions: Obesity Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING